Texas Senate Bill SB1790

Texas 2011 - 82nd Regular

• Out of Senate Committee: 5/13/11
• Report Pass: 5/13/11

Caption

Relating to distributing or prescribing abortion-inducing drugs; providing an administrative penalty.

Impact

This legislation holds significant implications for state laws regarding abortion practices. By formally codifying the definition of abortion-inducing drugs and the responsibilities of prescribing physicians, the bill seeks to tighten state control over abortion procedures. The inclusion of specific requirements such as documenting medical examinations and establishing emergency care protocols aims to ensure patient safety while also reinforcing state healthcare standards. The bill ultimately centralizes regulatory authority over abortion-related medical practices within the Texas Medical Board, which will be tasked with enforcement.

Summary

SB1790 seeks to regulate the distribution and prescription of abortion-inducing drugs in Texas. It amends the Health and Safety Code to include a new subchapter specifically focusing on the protocols that physicians must follow before prescribing these drugs. Essential provisions of the bill require physicians to conduct a thorough examination of the pregnant patient, establish the gestational age, and ensure that the prescription adheres strictly to the FDA-approved protocol for the abortion-inducing drug. Furthermore, it mandates that physicians provide a drug label to the patient that outlines the protocol and usage, signifying an emphasis on informed consent.

Contention

Debate surrounding SB1790 has focused on the implications for women's health rights and access to abortion services in Texas. Proponents argue that the strict guidelines are essential for protecting both patients and ensuring that medical practices follow established safety protocols. They maintain that these regulations promote accountability among healthcare providers. Conversely, opponents view the bill as a legislative overreach that could effectively limit access to abortion services and impose unnecessary barriers on women seeking medical assistance. Concerns have been raised about the potential impact on vulnerable populations who might find it increasingly difficult to obtain necessary care due to heightened restrictions.